Viewing Study NCT07252050


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2025-12-25 @ 2:33 PM
Study NCT ID: NCT07252050
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-11-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Sponsor: University of Colorado, Denver
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module